Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
World Journal of Urology
|
November 26, 2025
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma in the setting of clinical node positive disease: analysis of the ROBUUST registry
Margaret F Meagher, Zhenjie Wu, Antonio Franco, et al.
BJU International
|
September 12, 2024
Robot-assisted nephroureterectomy: surgical and mid-term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Zhenjie Wu, et al.
Urologic Oncology
|
March 25, 2025
Neoadjuvant chemotherapy prior to radical nephroureterectomy: Survival outcomes and recurrence patterns by pathologic node status
Farshad Sheybaee Moghaddam, Rashid K Sayyid, Alireza Ghoreifi, et al.
Minerva Urology and Nephrology
|
April 4, 2025
A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Eugenio Bologna, et al.
Minerva Urology and Nephrology
|
April 23, 2026
Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 Registry
Mariaconsiglia Ferriero, Gabriele Tuderti, Flavia Proietti, et al.
World Journal of Urology
|
April 18, 2025
Combined neoadjuvant and adjuvant therapy versus adjuvant therapy in high-risk upper tract urothelial carcinoma: a propensity matched multicenter analysis (ROBUUST 2.0 International Collaborative Group)
Ahmed Eraky, Reuben Ben-David, Gabriele Bignante, et al.
Urologic Oncology
|
March 3, 2026
Perioperative and oncologic outcomes of extirpative surgery for upper tract urothelial cancer in octogenarians
Taibo Li, Stephan Brönimann, Ahmed Eraky, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
World Journal of Urology
|
November 26, 2025
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma in the setting of clinical node positive disease: analysis of the ROBUUST registry
Margaret F Meagher, Zhenjie Wu, Antonio Franco, et al.
BJU International
|
September 12, 2024
Robot-assisted nephroureterectomy: surgical and mid-term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Zhenjie Wu, et al.
Urologic Oncology
|
March 25, 2025
Neoadjuvant chemotherapy prior to radical nephroureterectomy: Survival outcomes and recurrence patterns by pathologic node status
Farshad Sheybaee Moghaddam, Rashid K Sayyid, Alireza Ghoreifi, et al.
Minerva Urology and Nephrology
|
April 4, 2025
A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group)
Francesco Ditonno, Antonio Franco, Eugenio Bologna, et al.
Minerva Urology and Nephrology
|
April 23, 2026
Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 Registry
Mariaconsiglia Ferriero, Gabriele Tuderti, Flavia Proietti, et al.
World Journal of Urology
|
April 18, 2025
Combined neoadjuvant and adjuvant therapy versus adjuvant therapy in high-risk upper tract urothelial carcinoma: a propensity matched multicenter analysis (ROBUUST 2.0 International Collaborative Group)
Ahmed Eraky, Reuben Ben-David, Gabriele Bignante, et al.
Urologic Oncology
|
March 3, 2026
Perioperative and oncologic outcomes of extirpative surgery for upper tract urothelial cancer in octogenarians
Taibo Li, Stephan Brönimann, Ahmed Eraky, et al.
Page
of 2